TopNewsOn
Health

Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy

Medical Xpress·November 19, 2026

Patients with multiple myeloma who developed a serious gastrointestinal side effect after treatment with chimeric antigen receptor (CAR) T cell therapy had significantly more CAR T cells persisting in their bloodstream, according to new research from The University of Texas MD Anderson Cancer Center.

Read the full story at Medical Xpress →